- Market Capitalization, $K 343,791
- Shares Outstanding, K 324,331
- Annual Sales, $ 174,880 K
- Annual Income, $ -1,357 M
- 60-Month Beta 2.58
- Price/Sales 2.10
- Price/Cash Flow N/A
- Price/Book 0.70
|Period||Period Low||Period High||Performance|
| || |
+0.1690 (+19.18%)since 01/06/23
| || |
-0.2600 (-19.85%)since 11/04/22
| || |
-3.1600 (-75.06%)since 02/04/22
There's more evidence now favoring medical marijuana legalization. But medical marijuana is already legal in most states.
Do the rewards outweigh the risks in cannabis stocks right now?
While marijuana legalization has been rising, the industry is witnessing increased regulations. Moreover, the sector’s revenues have been declining recently. Hence, marijuana stocks Tilray Brands (TLRY),...
Here is how Aurora Cannabis Inc. (ACB) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Even some of the industry's stalwarts are showing signs of stress.
Aurora's long-term valuation proposition is murky at best.
/PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide,...
/CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide,...
With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.
|3rd Resistance Point||1.1867|
|2nd Resistance Point||1.1433|
|1st Resistance Point||1.0967|
|1st Support Level||1.0067|
|2nd Support Level||0.9633|
|3rd Support Level||0.9167|